184 related articles for article (PubMed ID: 28945795)
21. Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.
Chandra A; Jahangiri A; Chen W; Nguyen AT; Yagnik G; Pereira MP; Jain S; Garcia JH; Shah SS; Wadhwa H; Joshi RS; Weiss J; Wolf KJ; Lin JG; Müller S; Rick JW; Diaz AA; Gilbert LA; Kumar S; Aghi MK
Cancer Res; 2020 Apr; 80(7):1498-1511. PubMed ID: 32041837
[TBL] [Abstract][Full Text] [Related]
22. Qualitative and Quantitative Analysis of IDH1 Mutation in Progressive Gliomas by Allele-Specific qPCR and Western Blot Analysis.
Perrech M; Dreher L; Röhn G; Stavrinou P; Krischek B; Toliat M; Goldbrunner R; Timmer M
Technol Cancer Res Treat; 2019 Jan; 18():1533033819828396. PubMed ID: 30943868
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA HOTTIP promotes hypoxia-induced epithelial-mesenchymal transition of malignant glioma by regulating the miR-101/ZEB1 axis.
Zhang S; Wang W; Liu G; Xie S; Li Q; Li Y; Lin Z
Biomed Pharmacother; 2017 Nov; 95():711-720. PubMed ID: 28886531
[TBL] [Abstract][Full Text] [Related]
24. ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiation.
Hanna GK; Madany M; Tay ASS; Edwards LA; Kim S; Michael JS; Nuno M; Thomas T; Li A; Berel D; Black KL; Fan X; Zhang W; Rudnick JD; Wang R; Yu JS
J Neurosurg; 2023 May; 138(5):1313-1324. PubMed ID: 36115050
[TBL] [Abstract][Full Text] [Related]
25. Twist predicts poor outcome of patients with astrocytic glioma.
Nordfors K; Haapasalo J; Mäkelä K; Granberg KJ; Nykter M; Korja M; Paavonen T; Haapasalo H; Soini Y
J Clin Pathol; 2015 Nov; 68(11):905-12. PubMed ID: 26163539
[TBL] [Abstract][Full Text] [Related]
26. LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.
Du X; Tu Y; Liu S; Zhao P; Bao Z; Li C; Li J; Pan M; Ji J
J Cell Mol Med; 2020 Jan; 24(2):1474-1487. PubMed ID: 31856394
[TBL] [Abstract][Full Text] [Related]
27. The epithelial-mesenchymal transition of glioma cells promotes tissue factor expression via the miR200a/ZEB1 axis.
Sun Y; Jiang Y; Wang Y; Yu P; Su X; Song Y; Wang M; Li Y; Zhao L
Brain Res; 2022 Mar; 1778():147782. PubMed ID: 35026295
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.
Chen P; Liu H; Hou A; Sun X; Li B; Niu J; Hu L
Med Sci Monit; 2018 Feb; 24():1145-1151. PubMed ID: 29476046
[TBL] [Abstract][Full Text] [Related]
30. Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.
Popova SN; Bergqvist M; Dimberg A; Edqvist PH; Ekman S; Hesselager G; Ponten F; Smits A; Sooman L; Alafuzoff I
Histopathology; 2014 Feb; 64(3):365-79. PubMed ID: 24410805
[TBL] [Abstract][Full Text] [Related]
31. Molecular biology of high-grade gliomas: what should the clinician know?
Hofer S; Rushing E; Preusser M; Marosi C
Chin J Cancer; 2014 Jan; 33(1):4-7. PubMed ID: 24325789
[TBL] [Abstract][Full Text] [Related]
32. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Müller T; Gessi M; Waha A; Isselstein LJ; Luxen D; Freihoff D; Freihoff J; Becker A; Simon M; Hammes J; Denkhaus D; zur Mühlen A; Pietsch T; Waha A
Am J Pathol; 2012 Aug; 181(2):675-83. PubMed ID: 22688054
[TBL] [Abstract][Full Text] [Related]
33. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance.
Siebzehnrubl FA; Silver DJ; Tugertimur B; Deleyrolle LP; Siebzehnrubl D; Sarkisian MR; Devers KG; Yachnis AT; Kupper MD; Neal D; Nabilsi NH; Kladde MP; Suslov O; Brabletz S; Brabletz T; Reynolds BA; Steindler DA
EMBO Mol Med; 2013 Aug; 5(8):1196-212. PubMed ID: 23818228
[TBL] [Abstract][Full Text] [Related]
34. DZIP3 is a key factor to stratify IDH1 wild-type lower-grade gliomas.
Liang T; Zhou X; Li P; You G; Wang F; Wang P; Feng E
Aging (Albany NY); 2020 Nov; 12(24):24995-25004. PubMed ID: 33229627
[TBL] [Abstract][Full Text] [Related]
35. Molecular subtypes of glioblastoma are relevant to lower grade glioma.
Guan X; Vengoechea J; Zheng S; Sloan AE; Chen Y; Brat DJ; O'Neill BP; de Groot J; Yust-Katz S; Yung WK; Cohen ML; Aldape KD; Rosenfeld S; Verhaak RG; Barnholtz-Sloan JS
PLoS One; 2014; 9(3):e91216. PubMed ID: 24614622
[TBL] [Abstract][Full Text] [Related]
36. TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion.
Joseph JV; Conroy S; Tomar T; Eggens-Meijer E; Bhat K; Copray S; Walenkamp AM; Boddeke E; Balasubramanyian V; Wagemakers M; den Dunnen WF; Kruyt FA
Cell Death Dis; 2014 Oct; 5(10):e1443. PubMed ID: 25275602
[TBL] [Abstract][Full Text] [Related]
37. EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization.
Wilcock DM; Goold E; Zuromski LM; Davidson C; Mao Q; Sirohi D
J Neuropathol Exp Neurol; 2024 Apr; 83(5):338-344. PubMed ID: 38605523
[TBL] [Abstract][Full Text] [Related]
38. Combination genetic signature stratifies lower-grade gliomas better than histological grade.
Chan AK; Yao Y; Zhang Z; Shi Z; Chen L; Chung NY; Liu JS; Li KK; Chan DT; Poon WS; Wang Y; Zhou L; Ng HK
Oncotarget; 2015 Aug; 6(25):20885-901. PubMed ID: 26369702
[TBL] [Abstract][Full Text] [Related]
39. Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.
Rosmaninho P; Mükusch S; Piscopo V; Teixeira V; Raposo AA; Warta R; Bennewitz R; Tang Y; Herold-Mende C; Stifani S; Momma S; Castro DS
EMBO J; 2018 Aug; 37(15):. PubMed ID: 29903919
[TBL] [Abstract][Full Text] [Related]
40. Genetic Alterations of Epidermal Growth Factor Receptor in Glioblastoma: The Usefulness of Immunohistochemistry.
Lee M; Kang SY; Suh YL
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):589-598. PubMed ID: 29912767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
